3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
74
Colonic Neoplasms
24
Colonic Polyps
15
Adenoma
14
Neoplasms
5
Colorectal Neoplasms, Hereditary Nonpolyposis
5
Polyps
4
Pain
4
Gastrointestinal Neoplasms
4
Disease
4
Adenomatous Polyps
3
Stomach Neoplasms
2
Peptic Ulcer
2
Liver Cirrhosis
2
Intestinal Neoplasms
2
Intestinal Diseases
2
Inflammatory Bowel Diseases
2
Gastritis, Atrophic
2
Digestive System Diseases
2
Colitis, Ulcerative
2
Turcot syndrome
1
Tuberculosis
1
Signs and Symptoms, Digestive
1
Recurrence
1
Rectal Neoplasms
1
Rectal Diseases
1
Predictive Cancer Model
1
Personal Satisfaction
1
Patient Satisfaction
1
Pathologic Complete Response
1
Interventions
pembrolizumab
2
Oxaliplatin
2
Cyclophosphamide
2
Aspirin
2
ibrutinib
1
guadecitabine
1
XELOX
1
Sutures
1
Surgical Instruments
1
Optical Imaging
1
Irinotecan
1
Diagnosis
1
Colonoscopy
1
Cetuximab
1
Capecitabine
1
Ascorbic Acid
1
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Colonic Diseases
×
Colonoscopy
×
Clear all
NCT04287335
2020-12-08
CLEAR-C
Zhejiang University
Completed
4,758 enrolled